Multiple Assemblies exist for SMTL entry 5drt
Crystal structure of Dot1L in complex with inhibitor CPD2 [2-(2-(5-((2-chlorophenoxy)methyl)-1H-tetrazol-1-yl)acetyl)-N-(4-chlorophenyl)hydrazinecarboxamide]; X-RAY DIFFRACTION 2.69 Å

	SMTL ID 5drt.1 Ligands 2-({5-[(2-chlorophenoxy)methyl]-1H-tetrazol-1-yl}acetyl)-N-(4-chlorophenyl)hydrazinecarboxamide Polypeptides Histone-lysine N-methyltransferase, H3 lysine-79 specific Oligo-state monomer
	SMTL ID 5drt.2 Ligands POTASSIUM ION; 2-({5-[(2-chlorophenoxy)methyl]-1H-tetrazol-1-yl}acetyl)-N-(4-chlorophenyl)hydrazinecarboxamide Polypeptides Histone-lysine N-methyltransferase, H3 lysine-79 specific Oligo-state monomer